InvestorsHub Logo
Followers 280
Posts 59167
Boards Moderated 0
Alias Born 02/15/2012

Re: None

Thursday, 03/10/2016 9:52:06 AM

Thursday, March 10, 2016 9:52:06 AM

Post# of 14668
"We appreciate the opportunity to discuss our sub-micron delivery technology and its present and potential applications," says Anna Gluskin, EastGate's CEO. "We look forward to introducing the benefits of such delivery, that is now available through our nutraceutical products currently being sold on the market, to a larger audience,"

https://finance.yahoo.com/news/eastgate-biotech-ceo-anna-gluskin-133000798.html
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.